KJHP
TMO icon

K.J. Harrison & Partners’s Thermo Fisher Scientific TMO Stock Holding History

K.J. Harrison & Partners’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$953K Sell
1,938
-3,010
-61% -$1.63M 0.16% 138
2025
Q4 		$2.87M Buy
4,948
+1,070
+28% +$605K 0.38% 80
2025
Q3 		$2.04M Buy
3,878
+1,500
+63% +$698K 0.29% 93
2025
Q2 		$964K Sell
2,378
-33
-1% -$13.8K 0.16% 123
2025
Q1 		$1.2M Buy
2,411
+10
+0.4% +$5.42K 0.23% 107
2024
Q4 		$1.25M Sell
2,401
-1,977
-45% -$1.09M 0.2% 112
2024
Q3 		$2.61M Sell
4,378
-35
-0.8% -$20.7K 0.39% 69
2024
Q2 		$2.44M Buy
4,413
+46
+1% +$26.4K 0.4% 67
2024
Q1 		$2.54M Sell
4,367
-810
-16% -$455K 0.39% 72
2023
Q4 		$2.75M Buy
+5,177
New +$2.51M 0.47% 64
2023
Q3 		– Sell
-6,096
Closed -$3.17M – 202
2023
Q2 		$3.17M Buy
6,096
+1,110
+22% +$599K 0.57% 58
2023
Q1 		$2.87M Hold
4,986
– – 0.58% 53
2022
Q4 		$3.72M Hold
4,986
– – 0.73% 40
2022
Q3 		$2.53M Buy
4,986
+280
+6% +$157K 0.89% 33
2022
Q2 		$2.56M Sell
4,706
-4,150
-47% -$2.28M 0.69% 41
2022
Q1 		$5.23M Sell
8,856
-1,468
-14% -$843K 0.84% 29
2021
Q4 		$6.9M Sell
10,324
-1,452
-12% -$907K 0.98% 21
2021
Q3 		$6.77M Hold
11,776
– – 0.98% 21
2021
Q2 		$5.95K Sell
11,776
-482
-4% -$227K 0.62% 26
2021
Q1 		$5.59M Sell
12,258
-3,310
-21% -$1.58M 0.86% 25
2020
Q4 		$7.25M Sell
15,568
-2,700
-15% -$1.27M 1.18% 14
2020
Q3 		$8.07M Buy
18,268
+6,450
+55% +$2.66M 1.67% 8
2020
Q2 		$4.28M Buy
11,818
+78
+0.7% +$26.1K 1.17% 20
2020
Q1 		$3.33M Sell
11,740
-7,860
-40% -$2.48M 1.85% 16
2019
Q4 		$6.37M Sell
19,600
-2,900
-13% -$879K 1.6% 10
2019
Q3 		$6.55M Buy
22,500
+4,500
+25% +$1.29M 1.82% 8
2019
Q2 		$5.29M Buy
18,000
+5,000
+38% +$1.38M 1.68% 11
2019
Q1 		$3.56M Buy
13,000
+1,000
+8% +$249K 1.24% 23
2018
Q4 		$2.69M Sell
12,000
-3,000
-20% -$704K 1.64% 21
2018
Q3 		$3.66M Buy
+15,000
New +$3.45M 0.94% 32

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

K.J. Harrison & Partners's TMO Position: Q1 2026 in Review

K.J. Harrison & Partners reduced its Thermo Fisher Scientific (TMO) stake by 61% in Q1 2026, selling an estimated $1.63M and leaving 1,938 shares worth $953K. The position accounts for 0.16% of the portfolio, ranked #138.

K.J. Harrison & Partners first reported a position in TMO in Q3 2018 and has held it in 30 quarters since. The position peaked at $8.07M in Q3 2020. 2,590 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • K.J. Harrison & Partners held 1,938 shares of Thermo Fisher Scientific worth $953K as of Q1 2026.
  • K.J. Harrison & Partners sold 3,010 Thermo Fisher Scientific shares in Q1 2026, an estimated $1.63M.
  • Thermo Fisher Scientific made up 0.16% of K.J. Harrison & Partners's portfolio in Q1 2026, its #138 holding.
  • K.J. Harrison & Partners first reported a position in Thermo Fisher Scientific in Q3 2018 and has held it in 30 quarters since.
  • K.J. Harrison & Partners's Thermo Fisher Scientific position peaked at $8.07M in Q3 2020.
  • 2,590 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on K.J. Harrison & Partners's 13F filing for Q1 2026, filed 28 Apr 2026.